Oppenheimer Asset Management’s Terns Pharmaceuticals TERN Stock Holding History

Oppenheimer Asset Management’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,735	Closed	-$250K	–	1181
2026 Q1	$250K	Buy	+4,735	New	+$194K	﹤0.01%	1008

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Oppenheimer Asset Management's TERN Position: Q2 2026 in Review

Oppenheimer Asset Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 4,735 shares — an estimated $250K sold.

Oppenheimer Asset Management first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $250K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Oppenheimer Asset Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Oppenheimer Asset Management sold 4,735 Terns Pharmaceuticals shares in Q2 2026, an estimated $250K.
Oppenheimer Asset Management first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Oppenheimer Asset Management's Terns Pharmaceuticals position peaked at $250K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Oppenheimer Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.